<DOC>
	<DOCNO>NCT00955396</DOCNO>
	<brief_summary>In study investigator determine whether effect GSK1014802 ambulatory blood pressure . This randomized , double-blind , placebo-controlled , repeat dose , 2 period cross-over study conduct healthy male female subject . Approximately 60 subject randomise receive GSK1014802 400 mg bid placebo 36 day least 1 week treatment session . A follow-up occur 7-14 day last dose .</brief_summary>
	<brief_title>Study Investigate Effect GSK1014802 Ambulatory Blood Pressure</brief_title>
	<detailed_description />
	<criteria>Male female 18 65 year age inclusive . Healthy determine responsible experienced physician , base medical evaluation include medical history , physical examination , laboratory test , liver function cardiac monitoring . A female subject eligible participate : Nonchildbearing potential Childbearing potential agrees use contraception method . Male subject must agree use contraception method Body weight ≥ 50 kg BMI within range 19 40.0 kg/m2 ( inclusive ) . Arm circumference ≥ 24 ≤ 42 cm mid level . Capable give write informed consent , include compliance requirement restriction list consent form . A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month screen Current chronic history liver disease , know hepatic biliary abnormality ( exception Gilbert 's syndrome asymptomatic gallstone ) . A positive prestudy drug screen . Alcohol level legal limit drive screen detection alcohol within 24 h prior start dose Treatment Periods 1 2 . A positive test HIV antibody . History regular excessive alcohol consumption within 6 month study The subject participate clinical trial receive investigational product within following time period prior first dose day current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . Exposure four new chemical entity within 12 month prior first dose day . Use prescription nonprescription drug , include antihypertensive agent include diuretic , vitamin , herbal dietary supplement History sensitivity study medication , component thereof history drug allergy Where participation study would result donation blood blood product excess 500 mL within 90 day period . Pregnant female determine positive serum urine hCG test screen prior dosing . Lactating female . Unwillingness inability follow procedure outline protocol . Subject mentally legally incapacitate . Subjects work night whose work schedule include rotate night time ( 10:00 PM 6:00 AM ) work . Urinary cotinine level indicative smoke history regular use tobacco nicotinecontaining product within 6 month prior screen . Average daily caffeine intake equivalent &gt; 4 cup coffee &gt; 6 cup tea . Consumption red wine , seville orange , grapefruit grapefruit juice and/or pummelo , exotic citrus fruit , grapefruit hybrid fruit juices 7 day prior first dose study medication . Consumption age cheese meat , soy sauce tyramine rich source within 1 day prior baseline assessment . Current past history symptomatic orthostatic hypotension history unexplained vasovagal episode ( ) . History know suspected seizure , include infantile febrile , unexplained significant recent loss consciousness history significant head trauma loss consciousness family history ( first degree relative ) epilepsy seizure ( fit ) . Any history suicidal behaviour suicidal ideation type 4 5 CSSRS within 3 month screen visit . History currently diagnose sleep apnea .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>sodium channel blocker</keyword>
	<keyword>ambulatory blood pressure</keyword>
</DOC>